Nutra Pharma Corp., a biotechnology company that is developing drugs for HIV and Multiple Sclerosis (MS) has announced today that it was interviewed on Fox 2 News in St. Louis for its conservation partnership with the World Aquarium (www.WorldAquarium.net).
“We are honored to be working with the World Aquarium to help sponsor projects in conservation,” explained Rik J. Deitsch, Chairman and CEO of Nutra Pharma Corporation. “Nature provides us with tremendous resources, many of which have not yet been discovered. We feel that our partnership with the World Aquarium allows us to help contribute to an important issue facing our world,” he concluded.
To see the video of the newscast, please visit: http://www.myfoxstl.com/myfox/pages/InsideFox/Detail?contentId=1372203&version=2&locale=EN-US&layoutCode=VSTY&pageId=5.2.1
This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in Nutra Pharma's ("the Company") business plan. The Company's business is subject to various risks, which are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"). The feature on Fox 2 News about Nutra Pharma should not be construed as an indication in any way whatsoever of the value of the Company or its common stock. The Company's filings may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.